Terms: = Colorectal cancer AND MSI2, ENSG00000153944, 124540
12 results:
1. Musashi-2 potentiates colorectal cancer immune infiltration by regulating the post-translational modifications of HMGB1 to promote DCs maturation and migration.
Meng X; Na R; Peng X; Li H; Ouyang W; Zhou W; You X; Li Y; Pu X; Zhang K; Xia J; Wang J; Tang H; Zhuang G; Peng Z
Cell Commun Signal; 2024 Feb; 22(1):117. PubMed ID: 38347600
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic role and biologic features of Musashi-2 expression in colon polyps and during colorectal cancer progression.
Kharin L; Bychkov I; Karnaukhov N; Voloshin M; Fazliyeva R; Deneka A; Frantsiyants E; Kit O; Golemis E; Boumber Y
PLoS One; 2021; 16(7):e0252132. PubMed ID: 34237057
[TBL] [Abstract] [Full Text] [Related]
3. Integrated analysis of RNA-binding proteins in human colorectal cancer.
Fan X; Liu L; Shi Y; Guo F; Wang H; Zhao X; Zhong D; Li G
World J Surg Oncol; 2020 Aug; 18(1):222. PubMed ID: 32828126
[TBL] [Abstract] [Full Text] [Related]
4. Right and left-sided colon cancers - specificity of molecular mechanisms in tumorigenesis and progression.
Mukund K; Syulyukina N; Ramamoorthy S; Subramaniam S
BMC Cancer; 2020 Apr; 20(1):317. PubMed ID: 32293332
[TBL] [Abstract] [Full Text] [Related]
5. USP10 regulates Musashi-2 stability via deubiquitination and promotes tumour proliferation in colon cancer.
Ouyang SW; Liu TT; Liu XS; Zhu FX; Zhu FM; Liu XN; Peng ZH
FEBS Lett; 2019 Feb; 593(4):406-413. PubMed ID: 30604502
[TBL] [Abstract] [Full Text] [Related]
6. Natural product derivative Gossypolone inhibits Musashi family of RNA-binding proteins.
Lan L; Liu H; Smith AR; Appelman C; Yu J; Larsen S; Marquez RT; Wu X; Liu FY; Gao P; Gowthaman R; Karanicolas J; De Guzman RN; Rogers S; Aubé J; Neufeld KL; Xu L
BMC Cancer; 2018 Aug; 18(1):809. PubMed ID: 30097032
[TBL] [Abstract] [Full Text] [Related]
7. Stem Cells, cancer, and MUSASHI in Blood and Guts.
Kharas MG; Lengner CJ
Trends Cancer; 2017 May; 3(5):347-356. PubMed ID: 28718412
[TBL] [Abstract] [Full Text] [Related]
8. Musashi RNA-Binding Proteins as cancer Drivers and Novel Therapeutic Targets.
Kudinov AE; Karanicolas J; Golemis EA; Boumber Y
Clin Cancer Res; 2017 May; 23(9):2143-2153. PubMed ID: 28143872
[TBL] [Abstract] [Full Text] [Related]
9. Musashi2 as a novel predictive biomarker for liver metastasis and poor prognosis in colorectal cancer.
Zong Z; Zhou T; Rao L; Jiang Z; Li Y; Hou Z; Yang B; Han F; Chen S
Cancer Med; 2016 Apr; 5(4):623-30. PubMed ID: 26775684
[TBL] [Abstract] [Full Text] [Related]
10. The Msi Family of RNA-Binding Proteins Function Redundantly as Intestinal Oncoproteins.
Li N; Yousefi M; Nakauka-Ddamba A; Li F; Vandivier L; Parada K; Woo DH; Wang S; Naqvi AS; Rao S; Tobias J; Cedeno RJ; Minuesa G; Y K; Barlowe TS; Valvezan A; Shankar S; Deering RP; Klein PS; Jensen ST; Kharas MG; Gregory BD; Yu Z; Lengner CJ
Cell Rep; 2015 Dec; 13(11):2440-2455. PubMed ID: 26673327
[TBL] [Abstract] [Full Text] [Related]
11. Transformation of the intestinal epithelium by the msi2 RNA-binding protein.
Wang S; Li N; Yousefi M; Nakauka-Ddamba A; Li F; Parada K; Rao S; Minuesa G; Katz Y; Gregory BD; Kharas MG; Yu Z; Lengner CJ
Nat Commun; 2015 Mar; 6():6517. PubMed ID: 25774828
[TBL] [Abstract] [Full Text] [Related]
12. A WNT/p21 circuit directed by the C-clamp, a sequence-specific DNA binding domain in TCFs.
Hoverter NP; Ting JH; Sundaresh S; Baldi P; Waterman ML
Mol Cell Biol; 2012 Sep; 32(18):3648-62. PubMed ID: 22778133
[TBL] [Abstract] [Full Text] [Related]
